Jason Pozner
Boca Raton, FLNPI 1285768457
Payments from drug & device makers
What this record shows
This record is dominated by gifts: $15,728 of the $24,607 with a category attached, or 63.9%. AbbVie accounts for 71.1% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2019 at $17,636 and has fallen 96.2% since, to $664 in 2025.
Across 109 payments — averaging $225.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$18K
- Galderma Laboratories, L.p.$3K
- Davol Inc.$1K
- Endo Pharmaceuticals Inc.$960
- Merz North America, Inc.$398
- Hill Dermaceuticals, Inc.$380
- plus $971 from 11 others
Across 1 payment — averaging $257.90 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Davol Inc.$258
What the payments were for
- Consulting fees$3,94016%
- Food & beverage$4,93920%
- Gifts$15,72864%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 69 | $17,507 |
| Galderma Laboratories, L.p. | 5 | $3,195 |
| Davol Inc. | 11 | $1,196 |
| Endo Pharmaceuticals Inc. | 2 | $960 |
| Merz North America, Inc. | 3 | $398 |
| Hill Dermaceuticals, Inc. | 1 | $380 |
| BD | 3 | $272 |
| Tepha Inc | 1 | $149 |
| Apyx Medical Corporation | 3 | $138 |
| Dilon Technologies, Inc. | 3 | $131 |
| Revance Therapeutics, Inc. | 2 | $114 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $39 |
| Sientra, Inc. | 1 | $32 |
| Almirall LLC | 1 | $29 |
| Aclaris Therapeutics, Inc. | 1 | $23 |
| Mentor Worldwide LLC | 1 | $22 |
| Motiva USA, LLC | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NATRELLE$15,728
- Phasix Mesh$578
- ARISTA AH FLEXITIP$400
- Tolak$380
- BOTOX$368
- XEOMIN$327
- ASCLERA$327
- GalaFLEX$149
- NATRELLE SALINE-FILLED BREAST IMPLANTS$141
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ValacyclovirValacyclovir Hcl | 56 | $730 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 78 | $625 |
| Cephalexin | 104 | $401 |
| Azithromycin | 19 | $85 |
| Ondansetron OdtOndansetron | 34 | $83 |
| Diazepam | 18 | $39 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.